Global Climate Change Could Cause Rise in Airway Irritation

Share this content:
Global Climate Change Could Cause Rise in Airway Irritation
Global Climate Change Could Cause Rise in Airway Irritation

FRIDAY, June 9, 2017 (HealthDay News) -- Climate change may increase people's exposure to an outdoor fungus that can damage airway cells, leading to a rise in asthma and allergy symptoms, according to a study published online recently in the American Journal of Physiology-Cell Physiology.

The widespread fungus, called Alternaria alternata, produces spores in the dry, warm weather of late summer and early fall, said researchers from the University of Minnesota and the Mayo Clinic in Rochester, Minn. Previous research has shown that the fungus produces up to three times more spores when atmospheric carbon dioxide (CO2) levels are high. Rising CO2 emissions are thought to contribute to climate change. In some people, exposure to the spores can trigger allergy symptoms and asthma, the researchers explained.

For this study, the research team exposed cells from the linings of human airways to Alternaria and found it produced more cell damage. They warned that climate change might intensify the problem.

"These results suggest that continuing increases in atmospheric CO2 associated with global climate change will increase both the level of Alternaria exposure and antigenicity of spores that come in contact with the airways," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths